Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Meylan

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Transplantation|November 14, 2008
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?Frédéric Lamoth, Oriol Manuel, Jean-Pierre Venetz, et al.
Clinical Pharmacokinetics|August 5, 2009
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurementsNancy Perrottet, Laurent A Decosterd, Pascal Meylan, et al.
Clinical Pharmacokinetics|October 7, 2010
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristicsNicolas Widmer, Pascal Meylan, Anton Ivanyuk, et al.
Mycoses|February 18, 2018
Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patientsJade Couchepin, Anne-Sophie Brunel, Katia Jaton, et al.
Transplantation|February 14, 2014
Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infectionFrederic Tissot, Manuel Pascual, Roger Hullin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 10, 2013
Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series studyJuan Carlos Lozano Becerra, Robert Sieber, Gladys Martinetti, et al.
Swiss Medical Weekly|June 13, 2018
Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infectionManuela Kobas, Myriam Bickle Graz, Anita Carmen Truttmann, et al.
Journal of Virology|September 29, 2005
Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progressionGabriela Bleiber, Margaret May, Raquel Martinez, et al.
Journal of Neuroimmunology|November 6, 2007
Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune responseSamantha Jilek, Jens Kuhle, Pascal Meylan, et al.
Swiss Medical Weekly|April 4, 2019
Erratum to: Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infectionManuela Kobas, Myriam Bickle Graz, Anita Carmen Truttmann, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Transplantation|November 14, 2008
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?Frédéric Lamoth, Oriol Manuel, Jean-Pierre Venetz, et al.
Clinical Pharmacokinetics|August 5, 2009
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurementsNancy Perrottet, Laurent A Decosterd, Pascal Meylan, et al.
Clinical Pharmacokinetics|October 7, 2010
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristicsNicolas Widmer, Pascal Meylan, Anton Ivanyuk, et al.
Mycoses|February 18, 2018
Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patientsJade Couchepin, Anne-Sophie Brunel, Katia Jaton, et al.
Transplantation|February 14, 2014
Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infectionFrederic Tissot, Manuel Pascual, Roger Hullin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 10, 2013
Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series studyJuan Carlos Lozano Becerra, Robert Sieber, Gladys Martinetti, et al.
Swiss Medical Weekly|June 13, 2018
Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infectionManuela Kobas, Myriam Bickle Graz, Anita Carmen Truttmann, et al.
Journal of Virology|September 29, 2005
Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progressionGabriela Bleiber, Margaret May, Raquel Martinez, et al.
Journal of Neuroimmunology|November 6, 2007
Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune responseSamantha Jilek, Jens Kuhle, Pascal Meylan, et al.
Swiss Medical Weekly|April 4, 2019
Erratum to: Clinical characteristics, audiological and neurodevelopmental outcomes of newborns with congenital cytomegalovirus infectionManuela Kobas, Myriam Bickle Graz, Anita Carmen Truttmann, et al.
Pageof 10